BioSig Technologies, Inc. (BSGM)
USD 0.51
(-3.33%)
USD 0.51
(-3.33%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -28.15 Million USD | -4.37% |
| 2022 | -26.97 Million USD | 20.12% |
| 2021 | -33.21 Million USD | 42.41% |
| 2020 | -58.63 Million USD | -69.7% |
| 2019 | -34.41 Million USD | -100.29% |
| 2018 | -17.24 Million USD | -31.63% |
| 2017 | -13.1 Million USD | -22.12% |
| 2016 | -10.73 Million USD | 29.16% |
| 2015 | -9.45 Million USD | -92.9% |
| 2014 | -7.85 Million USD | -26.22% |
| 2013 | -6.22 Million USD | -176.27% |
| 2012 | -2.25 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -3.86 Million USD | -15.69% |
| 2024 Q1 | -3.1 Million USD | 45.11% |
| 2023 FY | - USD | -4.37% |
| 2023 Q2 | -10.81 Million USD | -48.12% |
| 2023 Q3 | -3.95 Million USD | 63.41% |
| 2023 Q4 | -6.07 Million USD | -53.46% |
| 2023 Q1 | -7.3 Million USD | -5.6% |
| 2022 Q2 | -5.64 Million USD | 29.53% |
| 2022 Q1 | -8.01 Million USD | 10.43% |
| 2022 Q4 | -6.91 Million USD | -8.01% |
| 2022 Q3 | -6.4 Million USD | -13.41% |
| 2022 FY | - USD | 20.12% |
| 2021 Q2 | -7.88 Million USD | 6.23% |
| 2021 FY | - USD | 42.41% |
| 2021 Q3 | -8.19 Million USD | -4.01% |
| 2021 Q4 | -8.94 Million USD | -9.07% |
| 2021 Q1 | -8.4 Million USD | 19.55% |
| 2020 Q1 | -12.78 Million USD | 16.01% |
| 2020 FY | - USD | -69.7% |
| 2020 Q3 | -13.07 Million USD | 41.43% |
| 2020 Q2 | -22.32 Million USD | -74.66% |
| 2020 Q4 | -10.44 Million USD | 20.09% |
| 2019 FY | - USD | -100.29% |
| 2019 Q1 | -5.86 Million USD | -2.91% |
| 2019 Q2 | -7.97 Million USD | -35.98% |
| 2019 Q3 | -5.48 Million USD | 31.26% |
| 2019 Q4 | -15.21 Million USD | -177.46% |
| 2018 FY | - USD | -31.63% |
| 2018 Q4 | -5.7 Million USD | -81.01% |
| 2018 Q3 | -3.14 Million USD | 45.35% |
| 2018 Q2 | -5.76 Million USD | -118.82% |
| 2018 Q1 | -2.63 Million USD | 52.98% |
| 2017 Q1 | -2.52 Million USD | -17.84% |
| 2017 FY | - USD | -22.12% |
| 2017 Q3 | -2.02 Million USD | 31.47% |
| 2017 Q4 | -5.6 Million USD | -176.64% |
| 2017 Q2 | -2.95 Million USD | -17.16% |
| 2016 Q1 | -2.04 Million USD | 4.92% |
| 2016 Q4 | -2.14 Million USD | -36.32% |
| 2016 Q3 | -1.57 Million USD | 68.45% |
| 2016 Q2 | -4.97 Million USD | -143.6% |
| 2016 FY | - USD | 29.16% |
| 2015 Q2 | -4.62 Million USD | -51.73% |
| 2015 FY | - USD | -92.9% |
| 2015 Q1 | -3.04 Million USD | -17.09% |
| 2015 Q4 | -2.14 Million USD | 59.63% |
| 2015 Q3 | -5.32 Million USD | -15.07% |
| 2014 Q4 | -2.6 Million USD | 33.92% |
| 2014 FY | - USD | -26.22% |
| 2014 Q1 | -723.71 Thousand USD | 17.38% |
| 2014 Q2 | -584.39 Thousand USD | 19.25% |
| 2014 Q3 | -3.94 Million USD | -574.29% |
| 2013 Q1 | -3.32 Million USD | -317.48% |
| 2013 FY | - USD | -176.27% |
| 2013 Q3 | -799.24 Thousand USD | 34.51% |
| 2013 Q2 | -1.22 Million USD | 63.3% |
| 2013 Q4 | -875.93 Thousand USD | -9.59% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | -796.62 Thousand USD | -25.72% |
| 2012 Q3 | -633.65 Thousand USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -108.727% |
| Cerus Corporation | -26.53 Million USD | -6.086% |
| OrthoPediatrics Corp. | -8.38 Million USD | -235.891% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -168.246% |
| Talis Biomedical Corporation | -66.04 Million USD | 57.376% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | -68.822% |
| Inogen, Inc. | -45.67 Million USD | 38.372% |
| Spectral AI, Inc. | -12.26 Million USD | -129.579% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 40.975% |
| CVRx, Inc. | -38.73 Million USD | 27.317% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -697.931% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -132.518% |
| Orthofix Medical Inc. | -86.98 Million USD | 67.637% |
| Venus Concept Inc. | -26.11 Million USD | -7.805% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 43.439% |
| Bioventus Inc. | -23.07 Million USD | -22.024% |
| BrainsWay Ltd. | -2.31 Million USD | -1118.131% |
| Envoy Medical, Inc. | -18.23 Million USD | -54.354% |
| electroCore, Inc. | -17.76 Million USD | -58.508% |
| IceCure Medical Ltd | -15.25 Million USD | -84.56% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 43.416% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | -67.012% |
| MaxCyte, Inc. | -44.12 Million USD | 36.206% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -139.461% |
| Nexalin Technology, Inc. | -5.69 Million USD | -394.568% |
| PAVmed Inc | -75.74 Million USD | 62.833% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 47.634% |
| RxSight, Inc. | -41.03 Million USD | 31.401% |
| Sight Sciences, Inc. | -49.41 Million USD | 43.031% |
| SI-BONE, Inc. | -34.44 Million USD | 18.275% |
| TELA Bio, Inc. | -40.63 Million USD | 30.719% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 51.712% |
| Treace Medical Concepts, Inc. | -39 Million USD | 27.833% |
| LivaNova PLC | 39.01 Million USD | 172.152% |
| 908 Devices Inc. | -34.02 Million USD | 17.264% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 74.545% |
| Nemaura Medical Inc. | -7.28 Million USD | -286.315% |
| NeuroPace, Inc. | -22.83 Million USD | -23.285% |
| LENSAR, Inc. | -8.71 Million USD | -223.055% |
| Apyx Medical Corporation | -18.11 Million USD | -55.427% |
| Cutera, Inc. | -136.56 Million USD | 79.386% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -732.87% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 1218.879% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | -34.123% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 107.339% |
| Axonics, Inc. | 7.77 Million USD | 462.071% |
| Outset Medical, Inc. | -153.78 Million USD | 81.695% |
| IRIDEX Corporation | -7.44 Million USD | -277.967% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 71.302% |
| IRadimed Corporation | 20.8 Million USD | 235.337% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -249.181% |
| INVO Bioscience, Inc. | -6.88 Million USD | -309.17% |
| Telesis Bio, Inc. | -40.49 Million USD | 30.479% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 176.754% |
| Varex Imaging Corporation | 67.2 Million USD | 141.891% |
| Quipt Home Medical Corp. | 44.07 Million USD | 163.876% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -158.979% |
| Pulmonx Corporation | -55.09 Million USD | 48.902% |
| Dynatronics Corporation | -976 Thousand USD | -2784.3% |
| Modular Medical, Inc. | -17.1 Million USD | -64.597% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -94.346% |
| Semler Scientific, Inc. | 23.58 Million USD | 219.34% |
| InMode Ltd. | 196.28 Million USD | 114.342% |
| Bruker Corporation | 599 Million USD | 104.7% |
| Cytosorbents Corporation | -28.81 Million USD | 2.29% |
| DexCom, Inc. | 916.7 Million USD | 103.071% |
| Align Technology, Inc. | 799.03 Million USD | 103.523% |
| Viveve Medical, Inc. | -20.61 Million USD | -36.543% |
| ZimVie Inc. | 91.07 Million USD | 130.91% |
| Movano Inc. | -29.12 Million USD | 3.344% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -538.634% |
| Nexalin Technology, Inc. | -5.69 Million USD | -394.568% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -697.931% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 85.538% |
| Profound Medical Corp. | -27.12 Million USD | -3.788% |
| Insulet Corporation | 323.6 Million USD | 108.699% |
| enVVeno Medical Corporation | -25.01 Million USD | -12.523% |
| Surmodics, Inc. | 1.18 Million USD | 2469.613% |
| iCAD, Inc. | -6.56 Million USD | -328.804% |
| Nuwellis, Inc. | -16.35 Million USD | -72.114% |
| Biotricity, Inc. | -8.82 Million USD | -218.873% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 70.937% |
| Aethlon Medical, Inc. | -11.84 Million USD | -137.579% |
| InspireMD, Inc. | -20.91 Million USD | -34.623% |
| PAVmed Inc. | -75.74 Million USD | 62.833% |
| BIOLASE, Inc. | -15.13 Million USD | -85.95% |
| Beyond Air, Inc. | -59.03 Million USD | 52.311% |
| FONAR Corporation | 28.25 Million USD | 199.644% |
| AxoGen, Inc. | -13.32 Million USD | -111.217% |
| Vivani Medical, Inc. | -26.6 Million USD | -5.799% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 214.71% |
| Inari Medical, Inc. | 7.11 Million USD | 495.768% |
| UFP Technologies, Inc. | 72.74 Million USD | 138.699% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -731.447% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -357.294% |
| Tenon Medical, Inc. | -15.52 Million USD | -81.292% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -84.403% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 32.127% |
| AdaptHealth Corp. | -171.09 Million USD | 83.546% |
| Sintx Technologies, Inc. | -6.6 Million USD | -326.53% |
| NanoVibronix, Inc. | -3.43 Million USD | -719.534% |
| Quanterix Corporation | -38.08 Million USD | 26.09% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -158.979% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 93936.667% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 89.848% |
| TransMedics Group, Inc. | -7.6 Million USD | -270.262% |
| ReWalk Robotics Ltd. | -21.76 Million USD | -29.341% |
| NeuroMetrix, Inc. | -7.09 Million USD | -296.727% |
| Hyperfine, Inc. | -47.06 Million USD | 40.182% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 51.719% |
| Biomerica, Inc. | -5.99 Million USD | -369.731% |
| Bone Biologics Corporation | 479.57 Thousand USD | 5970.026% |
| AVITA Medical, Inc. | -39.56 Million USD | 28.854% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -206.892% |
| Silk Road Medical, Inc | -45.08 Million USD | 37.553% |